BRIEF published on 03/12/2026 at 07:30, 6 months 13 days ago Closure of pharmaceutical production at Bichsel Pharmaceutical Production Galenica AG Social Plan Bichsel Closure Customer Transition
BRIEF published on 03/12/2026 at 07:30, 6 months 13 days ago Fermeture de la production pharmaceutique chez Bichsel Production Pharmaceutique Galenica AG Plan Social Bichsel Fermeture Transition Clients
BRIEF published on 03/12/2026 at 07:30, 6 months 13 days ago Galenica's Bichsel va fermer ses activités pharmaceutiques Service Client Suppressions D'emplois Plan Social Fermeture De Bichsel Stratégie De Galenica
BRIEF published on 03/12/2026 at 07:30, 6 months 13 days ago Galenica's Bichsel to Close Pharmaceutical Operations Customer Support Social Plan Bichsel Closure Job Redundancies Galenica Strategy
PRESS RELEASE published on 03/12/2026 at 07:25, 6 months 13 days ago Procédure de consultation terminée chez Bichsel Bichsel clôture la fabrication pharmaceutique après consultation, réduisant les suppressions d'emplois. Plan social mis en place pour les 152 postes concernés par la fermeture en 2026 Fabrication Pharmaceutique Suppressions D'emplois Plan Social Bichsel Fermeture 2026
PRESS RELEASE published on 03/12/2026 at 07:25, 6 months 13 days ago Consultation process at Bichsel completed Bichsel completes consultation process, to close pharmaceutical manufacturing operations with reduced job redundancies. Galenica's subsidiary to focus on home care services Galenica Pharmaceutical Manufacturing Consultation Process Redundancies Bichsel
BRIEF published on 03/10/2026 at 06:45, 6 months 15 days ago Galenica Reports Strong 2025 Results and Raises Mid-Term Guidance Sales Growth EBIT Increase Healthcare Services Galenica Results Diagnostics Expansion
BRIEF published on 03/10/2026 at 06:45, 6 months 15 days ago Galenica enregistre une croissance solide en 2025 et ajuste ses prévisions Croissance EBIT Diagnostic Galenica Pharmacies
BRIEF published on 03/10/2026 at 06:45, 6 months 15 days ago Galenica records solid growth in 2025 and adjusts its forecasts EBIT Growth Diagnosis Galenica Pharmacies
BRIEF published on 03/10/2026 at 06:45, 6 months 15 days ago Galenica annonce de solides résultats pour 2025 et relève ses prévisions à moyen terme. Croissance Des Ventes Services De Santé Augmentation Du Résultat D'exploitation Résultats De Galenica Développement Des Diagnostics
Published on 09/25/2026 at 14:00, 21 minutes ago Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 1 hour 21 minutes ago American Hotel Income Properties REIT LP Announces Corporate Update
Published on 09/25/2026 at 13:00, 1 hour 21 minutes ago UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach
Published on 09/25/2026 at 14:15, 6 minutes ago Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
Published on 09/25/2026 at 14:00, 21 minutes ago Original-Research: 2G Energy AG (von Parmantier & Cie. GmbH): Sell
Published on 09/25/2026 at 13:50, 31 minutes ago Chinese Opera Gala Opens in Zhouzhuang, Showcasing 46 Opera Genres Through November
Published on 09/25/2026 at 13:40, 41 minutes ago EQS-Adhoc: net digital AG: net digital AG raises 2026 revenue and EBITDA forecast
Published on 09/25/2026 at 12:26, 1 hour 55 minutes ago VitrA Tiles Introduces "The Code" concept and the New Codes of Design at Cersaie Fair
Published on 09/25/2026 at 07:00, 7 hours 21 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 19 hours 50 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 20 hours 21 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 20 hours 21 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026